To Be Discontinued Tablet Cardiovascular
Fluvastatin Sodium Tablet, E · 3 active FDA presentation rows for this drug
Brand: FLUVASTATIN SODIUM ER
FDA lists Fluvastatin Sodium Tablet, E as To Be Discontinued (Sandoz Inc.).
No availability text on this FDA row.
Fluvastatin Sodium Tablet, Extended Release: To Be Discontinued
FDA availability text is not recorded on this row. 3 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Fluvastatin Sodium Tablet, Extended Release
- Manufacturer
- Sandoz Inc.
- Dosage Form
- Tablet
- Presentation
- Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)
- Package NDC
- 0781-8017-01
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jan 27, 2026
- Last Updated
- Jan 27, 2026
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
fluvastatin
Side effects, interactions, warnings & more
Nearby, Other Fluvastatin Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.